Results 11 to 20 of about 58,938 (145)

Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease

open access: yesКардиоваскулярная терапия и профилактика, 2011
In the 1970s, pharmacological therapy interrupting the renin-angiotensin system was considered beneficial for patients with high-renin hypertension. Angiotensin-converting enzyme (ACE) inhibitors proved to be effective not only in patients with high ...
C. Napoli
doaj   +1 more source

Inhibition of the renin-angiotensin system causes concentric hypertrophy of renal arterioles in mice and humans

open access: yesJCI Insight, 2021
Inhibitors of the renin-angiotensin system (RAS) are widely used to treat hypertension. Using mice harboring fluorescent cell lineage tracers, single-cell RNA-Seq, and long-term inhibition of RAS in both mice and humans, we found that deletion of renin ...
Hirofumi Watanabe   +9 more
doaj   +1 more source

Aliskiren: An orally active renin inhibitor

open access: yesJournal of Pharmacy and Bioallied Sciences, 2011
Renin inhibitors are antihypertensive drugs that block the first step in the renin-angiotensin system. Their mechanism of action differs from that of the angiotensin-converting enzyme inhibitors and angiotensin-receptor antagonists, but like these drugs,
Pranay Wal   +3 more
doaj   +1 more source

Investigation renin inhibitor activity from flavonoids derivates by in silico study

open access: yesJournal of Advanced Pharmaceutical Technology & Research, 2023
Flavonoids have various pharmacological activities, such as antihypertensive, anticancer, and and antidiabetic effects. Several studies have shown that luteolin, quercetin, kaempferol, myricetin, naringenin, hesperetin, and epicatechin have ...
Aprilita Rina Yanti Eff   +4 more
doaj   +1 more source

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review

open access: yesFrontiers in Pharmacology, 2023
Chronic kidney disease presents a health challenge that has a complex underlying pathophysiology, both acquired and inherited. The pharmacotherapeutic treatment options available today lower the progression of the disease and improve the quality of life ...
Saeed Alshahrani
doaj   +1 more source

Acute Kidney Injury in a Case Series of Patients with Confirmed COVID-19 (Coronavirus Disease 2019): Role of Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Blockade

open access: yesCase Reports in Nephrology, 2020
The renin-angiotensin system plays a very critical role in hypertension, diabetes, and kidney and heart diseases. The blockade of the renin-angiotensin system results in the prevention of progression of renal and cardiac damage.
Avantika Chenna   +7 more
doaj   +1 more source

Renin-Inhibitoren – Von 'transition-state' Analogen und Peptidmimetika zu blutdrucksenkenden Wirkstoffen

open access: yesCHIMIA, 1991
During the last 10 years, a great worldwide effort was devoted towards the discovery of orally active renin inhibitors as blood-pressure-lowering drugs.
Beat Weidmann
doaj   +2 more sources

Low Nitric Oxide Bioavailability Increases Renin Production in the Collecting Duct

open access: yesFrontiers in Physiology, 2020
In the kidney, the stimulation of renin production by the collecting duct (CD-renin) contributes to the development of hypertension. The CD is a major nephron segment for the synthesis of nitric oxide (NO), and low NO bioavailability in the renal medulla
Andrew C. Curnow   +11 more
doaj   +1 more source

The Renin-Angiotensin System Modulates Inflammatory Processes in Atherosclerosis: Evidence from Basic Research and Clinical Studies

open access: yesMediators of Inflammation, 2009
Recent evidence shows that the renin-angiotensin system is a crucial player in atherosclerotic processes. The regulation of arterial blood pressure was considered from its first description of the main mechanism involved.
Fabrizio Montecucco   +2 more
doaj   +1 more source

Hyperkalemia and Renin–Angiotensin–Aldosterone System Inhibitors Dose Therapy in Heart Failure With Reduced Ejection Fraction

open access: yesCardiac Failure Review, 2019
Renin–angiotensin–aldosterone system inhibitors (RAASi) are known to improve outcomes in patients who have heart failure with reduced ejection fraction (HFrEF).
Giuseppe MC Rosano   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy